KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
301207 Hualan Biological Vaccine Inc.
- 19.00
- -0.22-1.14%
Market Closed Dec 13 15:00 CST
11.42BMarket Cap22.95P/E (TTM)
19.15High18.58Low75.12KlotVolume19.15Open19.22Pre Close141.18MTurnover5.30%Turnover Ratio13.28P/E (Static)601.03MShares29.0952wk High1.87P/B2.69BFloat Cap15.4252wk Low23.06Limit Up141.65MShs Float52.25Historical High15.38Limit Down2.97%Amplitude15.42Historical Low0.60Dividend TTM18.79Avg Price44.09KlotAsk3.16%Div YieldTTM100Lot Size29.46KlotBid
Hualan Biological Vaccine Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -44.28%957.36M | -76.25%35.53M | -76.36%34.22M | 32.03%2.41B | 10.15%1.72B | -85.89%149.6M | 892.96%144.76M | -0.23%1.83B | 11.99%1.56B | 9,624.76%1.06B |
| Operating revenue | -44.28%957.36M | -76.25%35.53M | -76.36%34.22M | 32.03%2.41B | 10.15%1.72B | -85.89%149.6M | 892.96%144.76M | -0.23%1.83B | 11.99%1.56B | 9,624.76%1.06B |
| Other operating revenue | ---- | 91.71%1.14M | ---- | -23.59%1.2M | ---- | -72.50%595.54K | ---- | -2.77%1.57M | ---- | 254.62%2.17M |
| Total operating cost | -27.70%757.73M | -3.95%122.3M | -40.69%53.56M | 23.92%1.41B | 4.06%1.05B | -82.79%127.33M | 125.98%90.31M | 10.10%1.14B | 24.68%1.01B | 495.38%739.88M |
| Operating cost | -8.89%181.38M | 670.79%8.73M | 1,163.02%3.41M | 32.03%287.1M | 5.55%199.07M | -101.25%-1.53M | -236.44%-320.33K | -1.50%217.45M | 15.54%188.61M | 12,684.18%122.57M |
| Operating tax surcharges | -25.06%8.38M | -10.82%3.5M | -19.49%1.6M | 20.53%15.18M | 10.19%11.19M | -42.30%3.92M | 38.52%1.99M | 16.17%12.59M | 24.03%10.15M | 253.88%6.79M |
| Operating expense | -41.95%411.83M | -45.66%22.17M | -53.23%20.42M | 39.43%948.99M | 11.41%709.39M | -91.67%40.8M | 3,927.65%43.66M | 16.75%680.63M | 32.88%636.72M | 5,109.13%490.01M |
| Administration expense | 37.71%83.28M | 39.47%48.01M | -26.33%12.65M | -27.06%69.82M | -7.71%60.48M | -14.36%34.43M | 248.17%17.18M | 48.32%95.72M | 24.65%65.53M | 11.28%40.2M |
| Financial expense | -110.10%-7.66M | -319.69%-6.95M | -197.93%-3.54M | 8.30%-5.02M | 8.97%-3.65M | 32.16%-1.66M | -47.27%-1.19M | -166.76%-5.48M | 3.14%-4.01M | 29.39%-2.44M |
| -Interest expense (Financial expense) | 0.38%4.4M | -3.37%2.87M | 1.27%1.33M | -43.11%6.08M | -51.20%4.38M | -56.43%2.97M | -58.18%1.32M | -19.70%10.69M | 16.01%8.98M | 70.15%6.81M |
| -Interest Income (Financial expense) | -48.14%-12.12M | -98.72%-9.8M | -86.14%-4.81M | 30.32%-11.44M | 36.88%-8.18M | 46.46%-4.93M | 34.29%-2.59M | -224.48%-16.41M | -7.77%-12.97M | -22.58%-9.21M |
| Research and development | 12.61%80.51M | -8.83%46.84M | -34.39%19.02M | -32.33%91.11M | -35.06%71.49M | -37.92%51.37M | -17.88%28.99M | -6.58%134.64M | 1.28%110.1M | 4.32%82.74M |
| Credit Impairment Loss | 195.97%22.49M | 32.95%57.13M | 61.41%33.91M | 25.69%-21.38M | 36.58%-23.44M | 297.74%42.97M | 41.34%21.01M | -2,679.67%-28.77M | -586.55%-36.96M | -142.55%-21.73M |
| Asset Impairment Loss | ---- | ---- | ---- | 37.45%-94.92M | ---- | ---- | ---- | -13.87%-151.74M | ---- | ---- |
| Other net revenue | 58.04%106.24M | 7.17%111.35M | 22.11%62.83M | 106.98%6.8M | 184.84%67.22M | 528.25%103.9M | 182.32%51.45M | -6.61%-97.44M | 31.11%23.6M | -75.00%16.54M |
| Fair value change income | -36.86%19.03M | -17.95%14.76M | 1.68%9.46M | 135.50%39.68M | 153.11%30.14M | 213.95%17.98M | 551.82%9.31M | 18.26%16.85M | 38.69%11.91M | -32.08%5.73M |
| Invest income | 6.97%55.81M | -2.97%34.6M | -4.02%16.05M | 26.79%70.49M | 28.81%52.18M | 37.45%35.66M | 286.61%16.72M | 133.98%55.6M | 234.99%40.51M | 454.76%25.95M |
| Asset deal income | -937.46%-140.14K | -937.46%-140.14K | -937.46%-140.14K | -131.71%-198.92K | -73.11%16.73K | -73.11%16.73K | --16.73K | --627.23K | --62.24K | --62.24K |
| Other revenue | 8.56%9.04M | -31.17%5M | -19.38%3.55M | 31.40%13.13M | 3.09%8.33M | 11.31%7.27M | 301.88%4.4M | 104.93%10M | 198.66%8.08M | 141.45%6.53M |
| Operating profit | -58.53%305.87M | -80.52%24.58M | -58.93%43.49M | 70.44%1.01B | 27.96%737.51M | -62.58%126.18M | 1,578.75%105.9M | -16.17%592.63M | -4.43%576.36M | 814.24%337.22M |
| Add:Non operating Income | --1.55M | --1.55M | --0 | ---- | ---- | ---- | --100K | 905,954.96%311.41K | 324,037.59%111.41K | --0.08 |
| Less:Non operating expense | -41.20%1.52M | -43.99%969.94K | 339.45%184.25K | -8.38%3.18M | 141.21%2.58M | 784.87%1.73M | -69.06%41.93K | 182.56%3.47M | 72.20%1.07M | -56.74%195.7K |
| Total profit | -58.38%305.9M | -79.78%25.16M | -59.13%43.31M | 70.81%1.01B | 27.72%734.93M | -63.07%124.45M | 1,552.09%105.96M | -16.47%589.48M | -4.49%575.4M | 807.05%337.02M |
| Less:Income tax cost | -63.37%38.54M | -100.72%-116.32K | -60.65%4.72M | 110.34%146.91M | 48.82%105.21M | -58.21%16.23M | 286.02%11.99M | -17.61%69.84M | -4.85%70.7M | 307.85%38.84M |
| Net profit | -57.54%267.36M | -76.65%25.27M | -58.93%38.59M | 65.49%859.97M | 24.77%629.71M | -63.71%108.22M | 11,156.09%93.97M | -16.32%519.63M | -4.44%504.71M | 1,128.93%298.19M |
| Net profit from continuing operation | -57.54%267.36M | -76.65%25.27M | -58.93%38.59M | 65.49%859.97M | 24.77%629.71M | -63.71%108.22M | 11,156.09%93.97M | -16.32%519.63M | -4.44%504.71M | 1,128.93%298.19M |
| Net profit of parent company owners | -57.54%267.36M | -76.65%25.27M | -58.93%38.59M | 65.49%859.97M | 24.77%629.71M | -63.71%108.22M | 11,156.09%93.97M | -16.32%519.63M | -4.44%504.71M | 1,128.93%298.19M |
| Earning per share | ||||||||||
| Basic earning per share | -57.47%0.4463 | -76.66%0.0421 | -72.63%0.0643 | 62.55%1.4316 | 21.99%1.0495 | -64.91%0.1804 | 10,313.04%0.2349 | -48.94%0.8807 | -41.36%0.8603 | 738.63%0.5141 |
| Diluted earning per share | -57.47%0.4463 | -76.62%0.0421 | -72.62%0.0642 | 62.20%1.4275 | 21.99%1.0495 | -64.97%0.1801 | 10,295.65%0.2345 | -48.98%0.8801 | -41.36%0.8603 | 738.63%0.5141 |
| Other composite income | ||||||||||
| Total composite income | -57.54%267.36M | -76.65%25.27M | -58.93%38.59M | 65.49%859.97M | 24.77%629.71M | -63.71%108.22M | 11,156.09%93.97M | -16.32%519.63M | -4.44%504.71M | 1,128.93%298.19M |
| Total composite income of parent company owners | -57.54%267.36M | -76.65%25.27M | -58.93%38.59M | 65.49%859.97M | 24.77%629.71M | -63.71%108.22M | 11,156.09%93.97M | -16.32%519.63M | -4.44%504.71M | 1,128.93%298.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.